Skip to main content
Premium Trial:

Request an Annual Quote

Engaging Slim Shady

Janet Stemwedel first asked her readers what they would do if they were working with a scientist they feel might be "shady." Many of her readers says that they'd run from the situation, though they acknowledge they should try to get more information. In her next post, Stemwedel gives her thoughts, namely that working with a suspect scientist could hurt your career but that you'll still run into that person at meetings. "For both the individual scientist and the scientific community, the issue boils down to making your best decision in the absence of complete information," she writes, adding that you have to judge the pros of cons of engaging with the shady scientist and the aftermath.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.